Daniel Abdun-Nabi, President & CEO at Emergent BioSolutions Inc. (EBS), sold 31,508 shares at $42.50 ($1.3M) on 2017-11-03, disclosed to the SEC on 2017-11-07.
Open-market sale of $1.3M EBS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.50 | 11,508 | $489K | 36.3% |
| 2 | $42.92 | 20,000 | $858K | 63.7% |
| Total | $42.77 avg | 31,508 | $1.3M | 100% |
| Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |
| EBS | SELL | 2018-01-04 | $1.0M | — | Filing → |